Evidence map›Paper›PMID 36692328›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2023

Do Tobacco Companies Have an Incentive to Promote "Harm Reduction" Products?: The Role of Competition.

David T Levy, Frances Thirlway, David Sweanor, Alex Liber, Luz Maria Sanchez-Romero, Rafael Meza, Clifford E Douglas, K Michael Cummings

Open access · hybridAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Recent Trends in Cigarette and HTP Use in Japan: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Subculture wars: The struggle for the vape industry.The British journal of sociology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

David T LevyOncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.ORCID 0000-0001-5280-3612
Frances ThirlwaySociology Department, University of York, Heslington, York, UK.
David SweanorCentre for Health Law, Policy and Ethics, University of Ottawa, Ottawa, Ontario, Canada.
Alex LiberOncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.ORCID 0000-0001-7863-3906
Luz Maria Sanchez-RomeroOncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.ORCID 0000-0001-7951-3965
Rafael MezaDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID 0000-0002-1076-5037
Clifford E DouglasDepartment of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charlestown, SC, USA.
Georgetown University · USUniversity of Michigan · USMedical University of South Carolina · USUniversity of Ottawa · CAUniversity of York · GB

Funding

Research Project 3: Modeling the Impact of Tobacco Control Policies on Polytobacco Use and Associated Health DisparitiesU54CA229974 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Theodore Levy, David Mendez Emilien · 2018 to 2026
$39.2M
Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HAMMOND, DAVID · 2016 to 2025
$25.3M
Cancer Research UK 23886NCI NIH HHS P01 CA200512NCI NIH HHS P01CA200512NCI NIH HHS U54 CA229974
6 · The paper itself

Abstract

introductionSome cigarette companies have started to talk about replacing cigarettes with less harmful alternatives, which might include nicotine vaping products (NVPs), heated tobacco products (HTPs), and oral nicotine delivery products. We consider market competition as a primary driver of whether cigarette companies follow through on their stated intentions. AIMS AND

methodsWe focus on the behavior of cigarette companies in the United States. We compare competition in the pre- and post-2012 time periods, analyze the impact of the growth in NVPs on smoking prevalence and cigarette company profits, and examine the potential future role of competition.

resultsSince 2006, consumers have broadened their use of non-combustible nicotine delivery products (NCNDPs) to include, inter alia, NVPs, HTPs, and oral nicotine pouches. U.S. cigarette companies have acquired major stakes in each of these product categories which corresponds to a period of rapidly declining adult smoking prevalence, especially among younger adults (ages 18-24 years). The shifting dynamics of the nicotine product marketplace are also reflected in cigarette company stock prices. While cigarette companies are likely to promote HTPs and nicotine delivery products over NVPs, their incentives will be directly related to competition from independent firms, which in turn will depend on government regulation.

conclusionsAlthough cigarette companies will back alternatives to combusted tobacco when threatened by competition, the prospects for their lasting conversion to NCNDPs will depend on the extent of such competition, which will be influenced by government regulation of tobacco products. IMPLICATIONS: Regulations that limit competition from independent firms while also protecting cigarette company profits risk slowing or even reversing recent declines in smoking, especially among youth and young adults. Regulations that reduce the appeal and addictiveness of combusted tobacco products, such as higher cigarette taxes or a reduced nicotine standard, will encourage smokers to quit and/or switch to less harmful non-combusted forms of tobacco. The regulation of non-combustible nicotine delivery products and cigarettes should be proportionate to their relative risks, so that smokers have incentives to switch from combustibles to safer alternatives, and cigarette companies have incentives to promote safer products.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsVapingAdolescentHumansMotivationNicotineSmokingUnited StatesYoung AdultNicotine

Identifiers

PMID36692328
PMCPMC10664083
OpenAlexW4317868861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.